653
Views
3
CrossRef citations to date
0
Altmetric
Article; Medical Biotechnology

Vitamin D influences the prevalence of non-cutaneous carcinomas after kidney transplantation?

, , , &
Pages 1266-1270 | Received 04 Apr 2018, Accepted 25 May 2018, Published online: 19 Jun 2018

References

  • Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant. 2007;22(Suppl. 1):i4–i10.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl. 3):S1–S157.
  • Touvier M, Chan DS, Lau R, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1003–1016.
  • Chen P, Hu P, Xie D, et al. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat. 2010;121:469–477.
  • Pálmer HG, Sánchez-Carbayo M, Ordóñez-Morán P, et al. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res. 2003;63:7799–7806.
  • Ugalde-Altamirano J, Alvarez VD, Revuelta I, et al. Relationship between vitamin D blood levels and cancer development in renal transplant patients: a case-control study. Transplant Proc. 2016;48:2959–2961.
  • Obi Y, Ichimaru N, Hamano T, et al. Orally active vitamin D for potential chemoprevention of posttransplant malignancy. Cancer Prev Res. 2012;5:1229–1235.
  • Ducloux D, Courivaud C, Bamoulid J, et al. Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation. 2008;85:1755–1759.
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59.
  • Filipov JJ, Zlatkov BK, Dimitrov EP, et al. Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients. Biotechnol Biotechnol Equip. 2015;29(2):331–335.
  • Fuchs MA, Yuan C, Sato K, et al. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance). Ann Oncol. 2017;28:1359–1367.
  • Jamshidinaeini Y, Akbari ME, Abdollahi M, et al. Vitamin D status and risk of breast cancer in Iranian women: a case-control study. J Am Coll Nutr. 2016;35:639–646.
  • Moukayed M, Grant WB. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: a review of the epidemiology, clinical trials, and mechanisms. Rev Endocr Metab Disord. 2017;18:167–182.
  • Keyzer CA, Riphagen IJ, Joosten MM, et al. Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients. J Clin Endocrinol Metab. 2015;100(1):81–89.
  • Marcén R, Jimenez S, Fernández-Rodriguez A, et al. Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation? Nephrol Dial Transplant. 2012;27(Suppl. 4):iv47–52.
  • Mohr SB, Gorham ED, Kim J, et al. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res. 2014;34(3):1163–1166.
  • Bao BY, Yao J, Lee YF. 1α, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis. 2006;27(9):1883–1893.
  • Edwards BJ. Anticancer effects of vitamin D. Am J Hematol Oncol. 2015;11(10):26–36.
  • Zhang L, Wang S, Che X, et al. Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell Physiol Biochem. 2015;36(1):299–305.
  • Zgaga L, O'Sullivan F, Cantwell MM, et al. Markers of vitamin D exposure and esophageal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25(6):877–886.
  • Krajewski W, Dzięgała M, Kołodziej A, et al. Vitamin D and urological cancers. Centr Eur J Urol. 2016;69:139–147.
  • Afzal S, Bojesen SE, Nordestgaard BG. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem. 2013;59(5):771–780.
  • Roskies M, Dolev Y, Caglar D, et al. Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg. 2012;41(3):160–163.